3-rx.comCustomer Support
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics

\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>

Join our Mailing List


You are here : 3-RX.com > Home > Diabetes -

Insulin regimens comparable for diabetes control

DiabetesDec 21, 07

For patients with type 2 diabetes beginning insulin therapy, blood sugar control and quality of life seem to be similar with either flexible intensive insulin therapy (FIT) or conventional insulin therapy (CIT) according to a report in the journal Diabetes Care.

The authors note that CIT is based on fixed insulin dosing and fixed carbohydrate intake, whereas with FIT, the insulin dose is adjusted in accordance with blood sugar levels and desired carbohydrate intake. CIT is easier, but FIT offers more dietary freedom.

“It seems that the potential greater flexibility under FIT is not of major importance for the majority of patients with type 2 diabetes,” Dr. Christof Kloos from Friedrich-Schiller-University, Jena, Germany told Reuters Health. “In our study, FIT in type 2 diabetes did not lead to improved treatment satisfaction or quality of life. This contrasts to patients with type 1 diabetes.”

Kloos and colleagues investigated whether FIT and CIT provide equivalent outcomes in a study of adults with type 2 diabetes who had never received insulin before.

CIT and FIT were comparable in their ability to lower blood sugar levels and body weight. Moreover, no differences were seen between the regimens in terms of their effects on blood pressure or insulin dosage.

Twenty patients preferred to continue CIT, and 18 patients preferred to continue FIT, the investigators say.

“Due to our results, there is no medical reason to prefer either FIT or CIT,” Kloos said.

“In further research projects, our focus will be to single out patients with type 2 diabetes who may profit from greater flexibility,” Kloos said.

SOURCE: Diabetes Care, November 2007.

Print Version
comments powered by Disqus

  Implantable ‘artificial pancreas’ could help diabetes patients control their blood sugar
  Joslin researchers find drugs are effective for diabetic macular edema in new trial
  New superfoods could help key protein keep bodies healthy
  Poor quality of life may affect teens’ diabetes management
  Cancer drug protects against diabetes
  Amino acid’s increase is suspected in diabetes
  New Type 2 Diabetes Drug Onglyza Approved
  Mail order pharmacy use safe for people with diabetes
  Policy considerations pose options for leaders to reduce costly disparities in diabetes
  Cedars-Sinai study sheds light on bone marrow stem cell therapy for pancreatic recovery
  Obesity-Linked Diabetes in Children Resists Treatment
  Diabetes again linked to colon cancer risk


Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site